IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bratton Capital Management, L.P.

Q3 2019 Holdings

Filed 2019-11-13 | 2 holdings | $36.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aquestive Therapeutics Inc(AQST)COM03843E104$36.6M11,503,294100.0%
Denali Therapeutics Inc(DNLI)COM24823R105$14.6K953,0350.0%